Disease/Infection News

RSS

What is the dose-response association of device-measured vigorous physical activity with mortality and incident cardiovascular disease and cancer?

Researchers demonstrated the benefits of moderate amounts of vigorous physical activity (VPA) completed in short bouts in reducing the risk of heart diseases and cancers.

1 Nov 2022

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

WHO’s TAG-VE group presented the most recent evidence on Omicron evolution and genetic diversity.

1 Nov 2022

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Researchers examined virus-virus interactions using human lung cells coinfected with two co-circulating respiratory infection-causing viruses, respiratory syncytial virus (RSV) and influenza A virus (IAV).

1 Nov 2022

The serial interval and incubation period for symptom and rash onset for monkeypox virus infection during the current US outbreak

Researchers estimated the serial interval and incubation period of monkeypox virus (MPXV) infections for the 2022 disease outbreak in the United States (US).

1 Nov 2022

How does the ISG15/ISGylation system modulate Vaccinia virus infection?

Researchers demonstrated how interferon-stimulated gene 15 (ISG15) is involved in the Vaccinia virus (VACV) dissemination.

1 Nov 2022

What makes some humans mosquito magnets?

Researchers explored the reasons for the greater attractiveness of some individuals to mosquitoes.

1 Nov 2022

High incidence of CKD in the United States persists, study says

New onset chronic kidney disease (CKD) in people with diabetes is highest among racial and ethnic minority groups compared with white persons, a UCLA-Providence study finds.

1 Nov 2022

Cohort study determines how often COVID-19 symptoms recurred

Researchers at University of California San Diego School of Medicine, with colleagues from the ACTIV-2 trial, part of the U.S. government's response to COVID-19, investigated whether symptoms of COVID-19 recurred following a two-day symptom-free period in persons who did not receive any treatment for the disease.

1 Nov 2022

Novel delivery system selectively delivers antibiotics to specific targets

Physicists at McMaster University have identified a natural delivery system which can safely carry potent antibiotics throughout the body to selectively attack and kill bacteria by using red blood cells as a vehicle.

1 Nov 2022

People who had COVID-19 are more vulnerable to developing neurological symptoms

Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson's disease.

1 Nov 2022

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found.

31 Oct 2022

COVID-19 presents caregivers with unique challenges not seen in other patients

Roughly 21% of hospitalized COVID-19 patients at the height of the pandemic required an intensive care stay and the bulk were cared for by family upon discharge.

31 Oct 2022

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

Institute of Human Virology researchers at the University of Maryland School of Medicine (UMSOM) have received two five-year awards from the National Institutes of Health's National Cancer Institute (NCI) for a total of $7.5 million.

31 Oct 2022

COVID-19 pandemic increased deaths and disease caused by tuberculosis

A new report published by the World Health Organization indicated a decrease in global spending on essential TB services from US$6 billion in 2019 to US$5.4 billion in 2021.

31 Oct 2022

SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron

Researchers estimate the severity of infection with the SARS-CoV-2 Omicron BA.2 subvariant as compared to that caused by the Delta and Omicron variants.

31 Oct 2022

Increasing Awareness Surrounding Ataxia

In this interview, we speak to Dr. Lauren Moore from the National Ataxia Foundation about the condition and the importance of raising awareness for ataxia.

31 Oct 2022

New research suggests booster dose of Novavax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants

A new study evaluated the neutralizing antibody titers against the SARS-CoV-2 Omicron variant and its sub-lineages after two and three doses of the Novavax protein nanoparticle vaccine NVX-CoV2373.

31 Oct 2022

What is the impact of SARS-CoV-2 on HIV-1 infectivity?

In a new study, researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV envelope (E) proteins on human immunodeficiency virus type 1 (HIV-1) infectivity.

31 Oct 2022

Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals

Researchers from Italy investigated the risk of SARS-CoV-2 reinfection and hospitalization among individuals with vaccinations and previous SARS-CoV-2 infections.

31 Oct 2022

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

In a new study, researchers assessed the risk of colorectal cancer (CRC) with the intake of flavonoids.

31 Oct 2022

Disease/Infection News

What is the dose-response association of device-measured vigorous physical activity with mortality and incident cardiovascular disease and cancer?

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

The serial interval and incubation period for symptom and rash onset for monkeypox virus infection during the current US outbreak

How does the ISG15/ISGylation system modulate Vaccinia virus infection?

What makes some humans mosquito magnets?

High incidence of CKD in the United States persists, study says

Cohort study determines how often COVID-19 symptoms recurred

Novel delivery system selectively delivers antibiotics to specific targets

People who had COVID-19 are more vulnerable to developing neurological symptoms

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

COVID-19 presents caregivers with unique challenges not seen in other patients

IHV researchers receive $7.5 million to control cancer among people living with HIV in sub-Saharan Africa

COVID-19 pandemic increased deaths and disease caused by tuberculosis

SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron

Increasing Awareness Surrounding Ataxia

New research suggests booster dose of Novavax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants

What is the impact of SARS-CoV-2 on HIV-1 infectivity?

Italian study evaluates COVID-19 reinfection risk among previously infected and vaccinated individuals

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News